Facilitated By

San Antonio Medical Foundation

News

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...

    ... San Antonio Breast Cancer Symposium. Celcuity Presents Overall Survival ... Celcuity is a clinical-stage biotechnology company focused on ...

  • Imlunestrant offers new hope for ER-positive HER2-negative breast cancer - News-Medical

    ... San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024 ... Biotechnology, Merck Pharmaceuticals, Context Therapeutics, Scorpion ...

  • With new data, Lilly sets pace for next wave of breast cancer drugs | BioPharma Dive

    ... San Antonio Breast Cancer Symposium. The data were also published in ... Dimension gets $500M to bankroll biotech's convergence with tech ...

  • Authorities say the mystery disease in Congo might be malaria but more testing is needed

    ... Biomedical Research in Kinshasa, told The Associated Press. "But ... San Antonio taqueria to appear on 'Diners, Drive-Ins, and Dives' · AUSTIN ...

  • Biotech CEOs Convicted of Fraud and Insider Trading Over Misleading - Hoodline

    Two biotech CEOs were convicted of securities fraud, wire fraud ... SAN ANTONIO SAN DIEGO SEATTLE TAMPA WASHINGTON, D.C.. © 2024 SFist LLC ...